Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma
specificAnn Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE).
13
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma(13)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 53.8 |
| 2 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 53.8 |
| 3 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 53.8 |
| 4 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive | 53.8 |
| 5 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 53.8 |
| 6 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 53.8 |
| 7 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive | 53.8 |
| 8 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 53.8 |
| 9 | Cleveland Clinic Cancer CenterCleveland, OH | 53.8 |
| 10 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 53.8 |
| 11 | University of Illinois Cancer CenterChicago, IL | 53.8 |
| 12 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 53.8 |
| 13 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 53.8 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →